128 related articles for article (PubMed ID: 27642646)
1. The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation.
Mercado-Pimentel ME; Igarashi S; Dunn AM; Behbahani M; Miller C; Read CM; Jacob A
Austin J Med Oncol; 2016; 3(1):. PubMed ID: 27642646
[TBL] [Abstract][Full Text] [Related]
2. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.
Liu TM; Ling Y; Woyach JA; Beckwith K; Yeh YY; Hertlein E; Zhang X; Lehman A; Awan F; Jones JA; Andritsos LA; Maddocks K; MacMurray J; Salunke SB; Chen CS; Phelps MA; Byrd JC; Johnson AJ
Blood; 2015 Jan; 125(2):284-95. PubMed ID: 25293770
[TBL] [Abstract][Full Text] [Related]
3. OSU-T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells.
Li Z; Ren D; Chen C; Sun L; Fang K
Cell Biol Int; 2022 Oct; 46(10):1672-1681. PubMed ID: 35830716
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
[TBL] [Abstract][Full Text] [Related]
5. OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.
Van Belle K; Herman J; Waer M; Sprangers B; Louat T
J Immunol Res; 2018; 2018():2505818. PubMed ID: 30276218
[TBL] [Abstract][Full Text] [Related]
6. Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.
Shirley LA; McCarty S; Yang MC; Saji M; Zhang X; Phay J; Ringel MD; Chen CS
Surgery; 2016 Jan; 159(1):163-70. PubMed ID: 26549818
[TBL] [Abstract][Full Text] [Related]
7. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
[TBL] [Abstract][Full Text] [Related]
8. GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway.
Chen H; Cheng M; Gao P; Zhang X; Li G; Wang L; Qin L; Li H
Bioengineered; 2022 Apr; 13(4):10944-10955. PubMed ID: 35477364
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.
Mercado-Pimentel ME; Miller C; Rolph DN; Villalobos EF; Dunn AM; Mohan PM; Igarashi S; Liu X; Yrun-Duffy M; Patel NK; Read CM; Francis RH; Lane AI; Murugesh S; Jacob A
Otol Neurotol; 2017 Jan; 38(1):139-146. PubMed ID: 27755359
[TBL] [Abstract][Full Text] [Related]
10. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
[TBL] [Abstract][Full Text] [Related]
11. SiO
Dehghany Ashkezary M; Aboee-Mehrizi F; Moradi P
Cancer Gene Ther; 2017 Jan; 24(1):28-32. PubMed ID: 27982018
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
13. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.
Balendran A; Casamayor A; Deak M; Paterson A; Gaffney P; Currie R; Downes CP; Alessi DR
Curr Biol; 1999 Apr; 9(8):393-404. PubMed ID: 10226025
[TBL] [Abstract][Full Text] [Related]
14. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells.
Chou CC; Chuang HC; Salunke SB; Kulp SK; Chen CS
Oncotarget; 2015 Apr; 6(10):8271-85. PubMed ID: 25821081
[TBL] [Abstract][Full Text] [Related]
15. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS
Clin Cancer Res; 2007 Aug; 13(16):4750-8. PubMed ID: 17699852
[TBL] [Abstract][Full Text] [Related]
16. Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1.
Hill MM; Feng J; Hemmings BA
Curr Biol; 2002 Jul; 12(14):1251-5. PubMed ID: 12176337
[TBL] [Abstract][Full Text] [Related]
17. Integrin-linked kinase (ILK): a "hot" therapeutic target.
Yoganathan TN; Costello P; Chen X; Jabali M; Yan J; Leung D; Zhang Z; Yee A; Dedhar S; Sanghera J
Biochem Pharmacol; 2000 Oct; 60(8):1115-9. PubMed ID: 11007949
[TBL] [Abstract][Full Text] [Related]
18. Characterization of PDK2 activity against protein kinase B gamma.
Hodgkinson CP; Sale EM; Sale GJ
Biochemistry; 2002 Aug; 41(32):10351-9. PubMed ID: 12162751
[TBL] [Abstract][Full Text] [Related]
19. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
[TBL] [Abstract][Full Text] [Related]
20. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
